Efficacy and Safety of DEC103 in Pain Control Associated to Intrauterine Device (IUD) Insertion

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 3, 2023

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Pain
Interventions
DRUG

DEC103

The intervention is composed by two medications: An active sublingual pill and an active oral one.

DRUG

Placebo DEC103

The intervention is composed by two medications: A placebo sublingual pill and an placebo oral one.

Trial Locations (1)

Unknown

CEMICAMP - Centro de Pesquisas em Saúde Reprodutiva de Campinas, Campinas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EMS

INDUSTRY

NCT05800392 - Efficacy and Safety of DEC103 in Pain Control Associated to Intrauterine Device (IUD) Insertion | Biotech Hunter | Biotech Hunter